Genetic analysis uncovers pterygium risk linked to MMP-3 genotype in a relevant population, suggesting important predictive value.
MMP-3 rs3025058 may serve as a genetic biomarker for pterygium susceptibility prediction, potentially contributing to ECM dysregulation and disease progression.
No takes yet. Share an insight, caveat, or question.
CHEN et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: